Esfuerzos para vencer el cáncer

Martes 23 de Noviembre de 2010 21:35 AtlAtl
Imprimir PDF

altAtlatl Athletic Wear participa activamente en eventos destinados a recabar fondos para impulsar los estudios y esfuerzos destinados a terminar con el cáncer. ¡Apoyemos juntos esta noble causa!


altThink of it as a history-making opportunity for you to do something big about cancer, something epic. Like riding throughout Quebec's countryside for two full days - July 7-8, 2012. Sure, it sounds like a lot�and it�s meant to be.

The conquest of cancer is a monumental task and won�t be easy. But make no mistake, this event isn�t just for athletes or cycling enthusiasts. The Enbridge Ride to Conquer Cancer is for anyone who wants to challenge themselves for a great cause. Even people who haven�t ridden since they were 12. All you need is motivation, a bike, and a helmet. The rest is history. Be part of it. Visit www.conquercancer.ca


alt

The PharmaprixMD Weekend to End Women�s Cancers� benefiting the Segal Cancer Centre at the Jewish General Hospital is a Weekend you�ll never forget. It�s a Weekend to remember those lives we have lost to breast or gynecologic cancer and a Weekend to celebrate the lives we are saving. This is a Weekend creating hope for every woman�s future.

Since 2005, over $45 million has been raised by Weekend participants enabling numerous advances in cancer research and care. Proceeds continue to fund innovative research, treatment, and prevention programs for breast and gynecologic cancers at the Segal Cancer Centre at the Jewish General Hospital.

All of this is made possible because of people just like you! Be a part of our celebration on August 25-26 and customize the best Weekend experience for you. Choose to enjoy the full 2-Day, 60km distance for maximum impact, or try the 1-Day 32km distance. You can also designate your fundraising dollars to go specifically to breast cancer or gynecologic cancers. Whichever experience you choose, make YOUR Weekend matter!




Última actualización el Domingo 11 de Marzo de 2012 04:32